Holley, Rebecca J <br/><br/>
Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy.  [electronic resource] 

 -  Brain : a journal of neurology  01 2018 
 - 99-116 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2156 
<br/><br/><label>Standard No.: </label>10.1093/brain/awx311  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain--enzymology<br/>Cytokines--metabolism<br/>Disease Models, Animal<br/>Encephalitis--etiology<br/>Female<br/>Genetic Therapy--methods<br/>Gliosis--therapy<br/>Glycosaminoglycans--genetics<br/>Humans<br/>Liver--enzymology<br/>Macrophages--enzymology<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Mucopolysaccharidosis III--complications<br/>Prednisolone--therapeutic use<br/>Spleen--enzymology<br/>Stem Cells--physiology<br/>Sulfatases--genetics